These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 3221908)
1. Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity. Riser BL; Laybourn KA; Varani J Nat Immun Cell Growth Regul; 1988; 7(5-6):305-15. PubMed ID: 3221908 [TBL] [Abstract][Full Text] [Related]
2. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo. Yoshioka T; Sato S; Fujiwara H; Hamaoka T Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429 [TBL] [Abstract][Full Text] [Related]
3. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody. Keller R; Bächi T; Okumura K Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344 [TBL] [Abstract][Full Text] [Related]
4. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases. Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909 [TBL] [Abstract][Full Text] [Related]
5. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells. Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209 [TBL] [Abstract][Full Text] [Related]
6. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells. Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945 [TBL] [Abstract][Full Text] [Related]
8. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice]. Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003 [TBL] [Abstract][Full Text] [Related]
9. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice. Peres A; Nestel FP; Seemayer TA; Lapp WS J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120 [TBL] [Abstract][Full Text] [Related]
10. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307 [TBL] [Abstract][Full Text] [Related]
11. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin. Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295 [TBL] [Abstract][Full Text] [Related]
12. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice. Gorelik E Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083 [TBL] [Abstract][Full Text] [Related]
13. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity. Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. Hanna N; Schneider M J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604 [TBL] [Abstract][Full Text] [Related]
15. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes. Kawano Y; Taniguchi K; Toshitani A; Nomoto K J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664 [TBL] [Abstract][Full Text] [Related]
16. Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity. Gorelik E; Wiltrout RH; Brunda MJ; Bere WE; Herberman RB Clin Exp Metastasis; 1985; 3(2):111-23. PubMed ID: 4042460 [TBL] [Abstract][Full Text] [Related]
17. In vivo administration of anti-asialo-GM1 antibody enhances splenic clearance of Listeria monocytogenes. Schultheis RJ; Kearns RJ Nat Immun Cell Growth Regul; 1990; 9(6):376-86. PubMed ID: 2128370 [TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes. Suttles J; Schwarting GA; Stout RD J Immunol; 1986 Mar; 136(5):1586-91. PubMed ID: 2936802 [TBL] [Abstract][Full Text] [Related]
19. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. Stein-Streilein J; Guffee J J Immunol; 1986 Feb; 136(4):1435-41. PubMed ID: 3944461 [TBL] [Abstract][Full Text] [Related]
20. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice. Maruyama T; Watanabe K; Yanagawa T; Kasatani T; Kasuga A; Shimada A; Takei I; Suzuki Y; Kataoka K; Saruta T Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]